位置:首页 > 蛋白库 > PABP_DROME
PABP_DROME
ID   PABP_DROME              Reviewed;         634 AA.
AC   P21187; A4UZM5; Q0E932; Q9V8C3;
DT   01-MAY-1991, integrated into UniProtKB/Swiss-Prot.
DT   27-SEP-2005, sequence version 3.
DT   03-AUG-2022, entry version 199.
DE   RecName: Full=Polyadenylate-binding protein;
DE            Short=PABP;
DE            Short=Poly(A)-binding protein;
GN   Name=pAbp; ORFNames=CG5119;
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota;
OC   Neoptera; Endopterygota; Diptera; Brachycera; Muscomorpha; Ephydroidea;
OC   Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND DEVELOPMENTAL STAGE.
RC   TISSUE=Embryo;
RX   PubMed=2125288; DOI=10.1016/0378-1119(90)90256-q;
RA   Lefrere V., Vincent A., Amalric F.;
RT   "Drosophila melanogaster poly(A)-binding protein: cDNA cloning reveals an
RT   unusually long 3'-untranslated region of the mRNA, also present in other
RT   eukaryotic species.";
RL   Gene 96:219-225(1990).
RN   [2]
RP   SEQUENCE REVISION.
RX   PubMed=8482550; DOI=10.1016/0378-1119(93)90387-i;
RA   Lefrere V., Vincent A., Amalric F.;
RT   "Drosophila melanogaster poly(A)-binding protein: cDNA cloning reveals an
RT   unusually long 3'-untranslated region of the mRNA, also present in other
RT   eukaryotic species.";
RL   Gene 126:295-296(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley;
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X., Brandon R.C.,
RA   Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D., Wan K.H., Doyle C.,
RA   Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G., Abril J.F., Agbayani A.,
RA   An H.-J., Andrews-Pfannkoch C., Baldwin D., Ballew R.M., Basu A.,
RA   Baxendale J., Bayraktaroglu L., Beasley E.M., Beeson K.Y., Benos P.V.,
RA   Berman B.P., Bhandari D., Bolshakov S., Borkova D., Botchan M.R., Bouck J.,
RA   Brokstein P., Brottier P., Burtis K.C., Busam D.A., Butler H., Cadieu E.,
RA   Center A., Chandra I., Cherry J.M., Cawley S., Dahlke C., Davenport L.B.,
RA   Davies P., de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I.,
RA   Dietz S.M., Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C.,
RA   Dunn P., Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S.,
RA   Fleischmann W., Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M.,
RA   Glasser K., Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J., Hostin D.,
RA   Houston K.A., Howland T.J., Wei M.-H., Ibegwam C., Jalali M., Kalush F.,
RA   Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A., Kimmel B.E., Kodira C.D.,
RA   Kraft C.L., Kravitz S., Kulp D., Lai Z., Lasko P., Lei Y., Levitsky A.A.,
RA   Li J.H., Li Z., Liang Y., Lin X., Liu X., Mattei B., McIntosh T.C.,
RA   McLeod M.P., McPherson D., Merkulov G., Milshina N.V., Mobarry C.,
RA   Morris J., Moshrefi A., Mount S.M., Moy M., Murphy B., Murphy L.,
RA   Muzny D.M., Nelson D.L., Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R.,
RA   Pacleb J.M., Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V.,
RA   Reese M.G., Reinert K., Remington K., Saunders R.D.C., Scheeler F.,
RA   Shen H., Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E., Svirskas R.,
RA   Tector C., Turner R., Venter E., Wang A.H., Wang X., Wang Z.-Y.,
RA   Wassarman D.A., Weinstock G.M., Weissenbach J., Williams S.M., Woodage T.,
RA   Worley K.C., Wu D., Yang S., Yao Q.A., Ye J., Yeh R.-F., Zaveri J.S.,
RA   Zhan M., Zhang G., Zhao Q., Zheng L., Zheng X.H., Zhong F.N., Zhong W.,
RA   Zhou X., Zhu S.C., Zhu X., Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M.,
RA   Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [4]
RP   GENOME REANNOTATION.
RC   STRAIN=Berkeley;
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q., Stapleton M.,
RA   Yamada C., Ashburner M., Gelbart W.M., Rubin G.M., Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a systematic
RT   review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=Berkeley; TISSUE=Embryo;
RX   PubMed=12537569; DOI=10.1186/gb-2002-3-12-research0080;
RA   Stapleton M., Carlson J.W., Brokstein P., Yu C., Champe M., George R.A.,
RA   Guarin H., Kronmiller B., Pacleb J.M., Park S., Wan K.H., Rubin G.M.,
RA   Celniker S.E.;
RT   "A Drosophila full-length cDNA resource.";
RL   Genome Biol. 3:RESEARCH0080.1-RESEARCH0080.8(2002).
RN   [6]
RP   INTERACTION WITH GW.
RX   PubMed=19797087; DOI=10.1128/mcb.01081-09;
RA   Zekri L., Huntzinger E., Heimstadt S., Izaurralde E.;
RT   "The silencing domain of GW182 interacts with PABPC1 to promote
RT   translational repression and degradation of microRNA targets and is
RT   required for target release.";
RL   Mol. Cell. Biol. 29:6220-6231(2009).
RN   [7]
RP   INTERACTION WITH LARP.
RX   PubMed=19631203; DOI=10.1016/j.ydbio.2009.07.016;
RA   Blagden S.P., Gatt M.K., Archambault V., Lada K., Ichihara K., Lilley K.S.,
RA   Inoue Y.H., Glover D.M.;
RT   "Drosophila Larp associates with poly(A)-binding protein and is required
RT   for male fertility and syncytial embryo development.";
RL   Dev. Biol. 334:186-197(2009).
RN   [8]
RP   FUNCTION, IDENTIFICATION IN A COMPLEX WITH EIF4E1; CUP; TRAL AND ME31B, AND
RP   DEVELOPMENTAL STAGE.
RX   PubMed=28875934; DOI=10.7554/elife.27891;
RA   Wang M., Ly M., Lugowski A., Laver J.D., Lipshitz H.D., Smibert C.A.,
RA   Rissland O.S.;
RT   "ME31B globally represses maternal mRNAs by two distinct mechanisms during
RT   the Drosophila maternal-to-zygotic transition.";
RL   Elife 6:0-0(2017).
RN   [9]
RP   FUNCTION, IDENTIFICATION IN A COMPLEX WITH TYF; ATX2 AND LSM12A,
RP   IDENTIFICATION IN A COMPLEX WITH TYF; ATX2 AND ME31B, AND INTERACTION WITH
RP   ME31B; TYF AND ATX2.
RX   PubMed=28388438; DOI=10.1016/j.molcel.2017.03.004;
RA   Lee J., Yoo E., Lee H., Park K., Hur J.H., Lim C.;
RT   "LSM12 and ME31B/DDX6 Define Distinct Modes of Posttranscriptional
RT   Regulation by ATAXIN-2 Protein Complex in Drosophila Circadian Pacemaker
RT   Neurons.";
RL   Mol. Cell 66:129-140(2017).
CC   -!- FUNCTION: Binds the poly(A) tail of mRNA (PubMed:2125288). Since it
CC       interacts with the cap-associating translation initiation factor eIF4G,
CC       it is likely that it functions by linking Atx2 to the cap-binding
CC       complex (PubMed:28388438). Forms a complex with tyf and Atx2 which
CC       functions in adult circadian pacemaker neurons to sustain circadian
CC       rhythms likely by switching between activator and repressor modes of
CC       post-transcriptional regulation via interaction with Lsm12a or me31B,
CC       respectively (PubMed:28388438). The activator complex (Atx2-tyf
CC       activator complex) activates the TYF-dependent translation of per to
CC       maintain 24 hour periodicity in circadian locomotor behaviors, whereas
CC       the repressor complex (Atx2-Not1 repressor complex) promotes Not1-
CC       dependent post-transcriptional gene silencing and supports high-
CC       amplitude circadian rhythms in a per-independent manner
CC       (PubMed:28388438). In 0-1 hour embryos, forms a ribonucleoprotein
CC       complex (RNP) with me31B, eIF4E1, tral and cup which binds to various
CC       mRNAs including maternal mRNAs, and down-regulates their expression
CC       during the maternal-to-zygotic transition (PubMed:28875934).
CC       {ECO:0000269|PubMed:2125288, ECO:0000269|PubMed:28388438,
CC       ECO:0000269|PubMed:28875934}.
CC   -!- SUBUNIT: Core component of the neuromuscular Atx2 complex, composed of
CC       at least Atx2, tyf, pAbp, Lsm12a (PubMed:28388438). Interacts with Atx2
CC       (via PAM2 motif) (PubMed:28388438). Atx2 and pAbp form a subcomplex
CC       that can associate with the 5' cap of pre-mRNAs independently of tyf,
CC       Lsm12a or me31B (PubMed:28388438). Forms a ribonucleoprotein complex
CC       (RNP) containing at least me31B, eIF4E1, cup, tral and pAbp; this
CC       interaction is required for the translational silencing of maternal
CC       mRNAs during the maternal-to-zygotic transition (PubMed:28875934). In
CC       1-5 hour embryos, interaction with me31B is severely reduced and there
CC       is no detected interaction with cup and tral, however interaction with
CC       eIF4E1 and eIF4G1 remains unchanged (PubMed:28875934). Interacts with
CC       gw; this interaction interferes with the binding of pAbp to eIF4G and
CC       is required for miRNA-mediated silencing (PubMed:19797087). Interacts
CC       with larp (PubMed:19631203). {ECO:0000269|PubMed:19631203,
CC       ECO:0000269|PubMed:19797087, ECO:0000269|PubMed:28388438,
CC       ECO:0000269|PubMed:28875934}.
CC   -!- INTERACTION:
CC       P21187; P48598: eIF4E1; NbExp=2; IntAct=EBI-103658, EBI-198574;
CC       P21187; Q8SY33: gw; NbExp=11; IntAct=EBI-103658, EBI-160693;
CC       P21187; Q9W4M7: tyf; NbExp=3; IntAct=EBI-103658, EBI-194676;
CC       P21187; Q9UPQ9: TNRC6B; Xeno; NbExp=6; IntAct=EBI-103658, EBI-947158;
CC       P21187; Q9HCJ0: TNRC6C; Xeno; NbExp=5; IntAct=EBI-103658, EBI-6507625;
CC   -!- DEVELOPMENTAL STAGE: Expressed during the first 5 hrs of embryogenesis
CC       (at protein level) (PubMed:28875934). Expressed both maternally and
CC       zygotically throughout development (PubMed:2125288).
CC       {ECO:0000269|PubMed:2125288, ECO:0000269|PubMed:28875934}.
CC   -!- SIMILARITY: Belongs to the polyadenylate-binding protein type-1 family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L05109; AAA70421.1; -; mRNA.
DR   EMBL; AE013599; AAF57746.1; -; Genomic_DNA.
DR   EMBL; AE013599; AAM68175.1; -; Genomic_DNA.
DR   EMBL; AY118528; AAM49897.1; -; mRNA.
DR   PIR; S30887; S30887.
DR   RefSeq; NP_476667.1; NM_057319.5.
DR   RefSeq; NP_725749.1; NM_166264.4.
DR   RefSeq; NP_725750.1; NM_166265.2.
DR   AlphaFoldDB; P21187; -.
DR   SMR; P21187; -.
DR   BioGRID; 62753; 66.
DR   DIP; DIP-52140N; -.
DR   ELM; P21187; -.
DR   IntAct; P21187; 18.
DR   MINT; P21187; -.
DR   STRING; 7227.FBpp0085915; -.
DR   PaxDb; P21187; -.
DR   PRIDE; P21187; -.
DR   ABCD; P21187; 15 sequenced antibodies.
DR   DNASU; 37070; -.
DR   EnsemblMetazoa; FBtr0086736; FBpp0085915; FBgn0265297.
DR   EnsemblMetazoa; FBtr0086738; FBpp0085917; FBgn0265297.
DR   EnsemblMetazoa; FBtr0086740; FBpp0085919; FBgn0265297.
DR   GeneID; 37070; -.
DR   KEGG; dme:Dmel_CG5119; -.
DR   CTD; 37070; -.
DR   FlyBase; FBgn0265297; pAbp.
DR   VEuPathDB; VectorBase:FBgn0265297; -.
DR   eggNOG; KOG0123; Eukaryota.
DR   GeneTree; ENSGT00940000169027; -.
DR   HOGENOM; CLU_012062_22_2_1; -.
DR   InParanoid; P21187; -.
DR   OMA; ASPMEQK; -.
DR   OrthoDB; 1027234at2759; -.
DR   PhylomeDB; P21187; -.
DR   Reactome; R-DME-156827; L13a-mediated translational silencing of Ceruloplasmin expression.
DR   Reactome; R-DME-429947; Deadenylation of mRNA.
DR   Reactome; R-DME-450408; AUF1 (hnRNP D0) binds and destabilizes mRNA.
DR   Reactome; R-DME-72649; Translation initiation complex formation.
DR   Reactome; R-DME-975956; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC).
DR   Reactome; R-DME-975957; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC).
DR   SignaLink; P21187; -.
DR   BioGRID-ORCS; 37070; 1 hit in 3 CRISPR screens.
DR   ChiTaRS; pAbp; fly.
DR   GenomeRNAi; 37070; -.
DR   PRO; PR:P21187; -.
DR   Proteomes; UP000000803; Chromosome 2R.
DR   Bgee; FBgn0265297; Expressed in cleaving embryo and 30 other tissues.
DR   Genevisible; P21187; DM.
DR   GO; GO:0071013; C:catalytic step 2 spliceosome; HDA:FlyBase.
DR   GO; GO:0005737; C:cytoplasm; IDA:FlyBase.
DR   GO; GO:0010494; C:cytoplasmic stress granule; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; HDA:FlyBase.
DR   GO; GO:0005634; C:nucleus; HDA:FlyBase.
DR   GO; GO:0071011; C:precatalytic spliceosome; HDA:FlyBase.
DR   GO; GO:1990904; C:ribonucleoprotein complex; IDA:FlyBase.
DR   GO; GO:0045202; C:synapse; IEA:GOC.
DR   GO; GO:0003730; F:mRNA 3'-UTR binding; IDA:FlyBase.
DR   GO; GO:0003729; F:mRNA binding; ISS:FlyBase.
DR   GO; GO:0008143; F:poly(A) binding; ISS:FlyBase.
DR   GO; GO:0008266; F:poly(U) RNA binding; IBA:GO_Central.
DR   GO; GO:0003723; F:RNA binding; IBA:GO_Central.
DR   GO; GO:0007268; P:chemical synaptic transmission; IMP:FlyBase.
DR   GO; GO:0009953; P:dorsal/ventral pattern formation; IMP:FlyBase.
DR   GO; GO:0007112; P:male meiosis cytokinesis; IMP:FlyBase.
DR   GO; GO:0007140; P:male meiotic nuclear division; IMP:FlyBase.
DR   GO; GO:0000398; P:mRNA splicing, via spliceosome; IC:FlyBase.
DR   GO; GO:1901215; P:negative regulation of neuron death; IGI:FlyBase.
DR   GO; GO:0048599; P:oocyte development; IMP:FlyBase.
DR   GO; GO:0048477; P:oogenesis; IMP:FlyBase.
DR   GO; GO:0045727; P:positive regulation of translation; IGI:FlyBase.
DR   GO; GO:0045314; P:regulation of compound eye photoreceptor development; IGI:FlyBase.
DR   GO; GO:0007289; P:spermatid nucleus differentiation; IMP:FlyBase.
DR   GO; GO:0007283; P:spermatogenesis; IMP:FlyBase.
DR   CDD; cd12379; RRM2_I_PABPs; 1.
DR   Gene3D; 3.30.70.330; -; 4.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR036053; PABP-dom.
DR   InterPro; IPR006515; PABP_1234.
DR   InterPro; IPR002004; PABP_HYD.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR045305; RRM2_I_PABPs.
DR   InterPro; IPR000504; RRM_dom.
DR   Pfam; PF00658; PABP; 1.
DR   Pfam; PF00076; RRM_1; 4.
DR   SMART; SM00517; PolyA; 1.
DR   SMART; SM00360; RRM; 4.
DR   SUPFAM; SSF54928; SSF54928; 2.
DR   SUPFAM; SSF63570; SSF63570; 1.
DR   TIGRFAMs; TIGR01628; PABP-1234; 1.
DR   PROSITE; PS51309; PABC; 1.
DR   PROSITE; PS50102; RRM; 4.
PE   1: Evidence at protein level;
KW   Reference proteome; Repeat; RNA-binding.
FT   CHAIN           1..634
FT                   /note="Polyadenylate-binding protein"
FT                   /id="PRO_0000081713"
FT   DOMAIN          2..80
FT                   /note="RRM 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00176"
FT   DOMAIN          90..167
FT                   /note="RRM 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00176"
FT   DOMAIN          181..259
FT                   /note="RRM 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00176"
FT   DOMAIN          285..362
FT                   /note="RRM 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00176"
FT   DOMAIN          552..629
FT                   /note="PABC"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00641"
FT   CONFLICT        171..173
FT                   /note="REK -> Q (in Ref. 1; AAA70421)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        336..337
FT                   /note="AA -> PE (in Ref. 1; AAA70421)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        371
FT                   /note="H -> D (in Ref. 1; AAA70421)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   634 AA;  69925 MW;  A76B204ED206392E CRC64;
     MASLYVGDLP QDVNESGLFD KFSSAGPVLS IRVCRDVITR RSLGYAYVNF QQPADAERAL
     DTMNFDLVRN KPIRIMWSQR DPSLRRSGVG NVFIKNLDRA IDNKAIYDTF SAFGNILSCK
     VATDEKGNSK GYGFVHFETE EAANTSIDKV NGMLLNGKKV YVGKFIPRKE REKELGEKAK
     LFTNVYVKNF TEDFDDEKLK EFFEPYGKIT SYKVMSKEDG KSKGFGFVAF ETTEAAEAAV
     QALNGKDMGE GKSLYVARAQ KKAERQQELK RKFEELKQKR HESVFGVNLY VKNLDDTIDD
     DRLRIAFSPY GNITSAKVMT DEEGRSKGFG FVCFNAASEA TCAVTELNGR VVGSKPLYVA
     LAQRKEERKA HLASQYMRHM TGMRMQQLGQ IYQPNAASGF FVPTLPSNQR FFGSQVATQM
     RNTPRWVPQV RPPAAIQGVQ AGAAAAGGFQ GTAGAVPTQF RSAAAGARGA QPQVQGTHAA
     AAAANNMRNT GARAITGQQT AAPNMQIPGA QIAGGAQQRT SNYKYTSNMR NPPVPQLHQT
     QPIPQQLQGK NSEKLIASLL ANAKPQEQKQ ILGERLYPMI EHMHANLAGK ITGMLLEIEN
     SELLHMIEDQ EALKAKVEEA VAVLQVHRVT EPAN
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024